Organogenesis Holdings (ORGO) Share-based Compensation (2018 - 2026)

Organogenesis Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 7.99% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $13.6 million (up 17.59% YoY), while the FY2025 annual figure was $13.3 million, up 25.71% from the prior year.
• Share-based Compensation was $3.6 million for Q1 2026 at Organogenesis Holdings, down from $4.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.3 million in Q4 2025 to a low of $1.3 million in Q1 2022.
• Historically, Share-based Compensation has averaged $2.5 million across 5 years, with a median of $2.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Share-based Compensation soared 86.68% in 2022, then dropped 1.01% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $1.9 million in 2022, then advanced by 27.55% to $2.4 million in 2023, then rose by 22.19% to $2.9 million in 2024, then jumped by 49.57% to $4.3 million in 2025, then declined by 15.91% to $3.6 million in 2026.
• The last three Share-based Compensation figures came in at $3.6 million (Q1 2026), $4.3 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.